AC
CPHR

Armistice Capital’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Armistice Capital’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-300,000
Closed -$1.11M – 48
2015
Q3 		$1.11M Buy
+300,000
New +$2.08M 0.38% 35

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital's CPHR Position: Q4 2015 in Review

Armistice Capital sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2015, closing a stake of 300,000 shares — an estimated $1.11M sold.

Armistice Capital first reported a position in CPHR in Q3 2015 and held it in 1 quarter. The position peaked at $1.11M in Q3 2015. 21 funds tracked by Wall St. Rank hold CPHR as of Q4 2015.

  • Armistice Capital reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2015 after selling out during the quarter.
  • Armistice Capital sold 300,000 Cipher Pharmaceuticals Inc. shares in Q4 2015, an estimated $1.11M.
  • Armistice Capital first reported a position in Cipher Pharmaceuticals Inc. in Q3 2015 and held it in 1 quarter.
  • Armistice Capital's Cipher Pharmaceuticals Inc. position peaked at $1.11M in Q3 2015.
  • 21 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2015.

Based on Armistice Capital's 13F filing for Q4 2015, filed 16 Feb 2016.